Steve Miller

All filings by Steve Miller on record concern Catalyst Pharmaceuticals, Inc., in the capacity of senior executive. Between 11 January 2016 and 15 July 2026, the trades on record add up to 40 filings.

Both buying and selling appear: 1 purchase worth €13k, against 15 sales worth €12.3M. The net balance comes to €12.2M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 23 option exercises.

Most recently, on 17 July 2026, the filings show a transaction worth €30.1M in Catalyst Pharmaceuticals, Inc. The most recent open-market purchase was published on 12 January 2016, 3,937 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.